Macy Eric, Ho Ngoc J
Department of Allergy at the San DiegoMedical Center; Southern California Permanente Medical Group, University of California, San Diego, USA.
Perm J. 2011 Spring;15(2):31-7. doi: 10.7812/TPP/11-025.
There is little prospective data on the antibiotics prescribed and the adverse reactions associated with their use after penicillin skin testing.
Provide data on antibiotic use and new antibiotic "allergy" incidence after penicillin skin testing.
All patients who had penicillin skin testing at our Medical Center between 1-1-2000 and 12-31-2004 were followed through 12-31-2009. All therapeutic antibiotic use and all new "allergies" listed in their electronic medical records were reviewed.
There were 1684 study subjects of whom 1191 (70.7%) were female. There were 118 (7.0%) positive to at least one penicillin skin test reagent and 3 (0.2%) were positive only to amoxicillin. The mean follow-up period was 4.5 ± 2.9 years. Subjects were exposed to a mean of 8.2 ± 10.5 therapeutic antibiotic courses during follow-up. The highest new antibiotic "allergy" incidence rates in skin test-negative subjects were noted for penicillins, 2.9%, and sulfonamides, 2.7%, p = 0.9097. Females had higher overall incidences of new antibiotic "allergy," independent of skin test result. Penicillin skin test-negative females treated with penicillin had a nonsignificantly higher new penicillin "allergy" incidence, 3.3% per course versus 1.9% for males, p = 0.0644. Cephalosporins had new antibiotic "allergy" incidence rates not significantly different from tetracyclines, quinolones, macrolides, clindamycin, metronidazole, nitrofurantoin, and other antibiotics.
Females had higher new antibiotic "allergy" incidence rates. New "allergy" to cephalosporins occurred no more frequently than with non-beta-lactam-antibiotics, independent of skin test result. Sulfonamide antibiotics were associated with the higher rates of new antibiotic "allergy" than cephalosporins.
关于青霉素皮肤试验后所开具的抗生素及其使用相关不良反应的前瞻性数据较少。
提供青霉素皮肤试验后抗生素使用情况及新的抗生素“过敏”发生率的数据。
对2000年1月1日至2004年12月31日期间在我们医疗中心进行青霉素皮肤试验的所有患者进行随访,直至2009年12月31日。回顾了他们电子病历中所有的治疗性抗生素使用情况以及所有新记录的“过敏”情况。
共有1684名研究对象,其中1191名(70.7%)为女性。118名(7.0%)对至少一种青霉素皮肤试验试剂呈阳性,3名(0.2%)仅对阿莫西林呈阳性。平均随访期为4.5±2.9年。随访期间,研究对象平均接受了8.2±10.5个疗程的治疗性抗生素。皮肤试验阴性的研究对象中,青霉素类新抗生素“过敏”发生率最高,为2.9%,磺胺类为2.7%,p = 0.9097。女性新抗生素“过敏”的总体发生率较高,与皮肤试验结果无关。接受青霉素治疗的青霉素皮肤试验阴性女性,新的青霉素“过敏”发生率略高,每疗程为3.3%,而男性为1.9%,p = 0.0644。头孢菌素类的新抗生素“过敏”发生率与四环素类、喹诺酮类、大环内酯类、克林霉素、甲硝唑、呋喃妥因及其他抗生素无显著差异。
女性新抗生素“过敏”发生率较高。无论皮肤试验结果如何,头孢菌素类新“过敏”的发生频率并不高于非β-内酰胺类抗生素。磺胺类抗生素比头孢菌素类与更高的新抗生素“过敏”发生率相关。